Page 32 - கூட்டு நிர்வகித்தல் இயக்குனர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கூட்டு நிர்வகித்தல் இயக்குனர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கூட்டு நிர்வகித்தல் இயக்குனர் Today - Breaking & Trending Today

Airline stocks can be a good momentum play

Airline stocks can be a good momentum play
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Thomas Cook , Prabhudas Lilladher , Dilip Bhat , Joint Managing Director , தாமஸ் சமைக்கவும் , பிரபுடச் லில்லாதர் , நீர்த்துப்போக பட் , கூட்டு நிர்வகித்தல் இயக்குனர் ,

Parfetts Caps Record Year With Tax-Free Bonus For Staff

Parfetts Caps Record Year With Tax-Free Bonus For Staff
kamcity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kamcity.com Daily Mail and Mail on Sunday newspapers.

Wholesaler Parfetts , Guy Swindell , Joint Managing Director , பையன் ஸ்விண்டெல் , கூட்டு நிர்வகித்தல் இயக்குனர் ,

Final Phase-3 results of Covaxin show efficacy of 77.8% against Covid


Final Phase-3 results of Covaxin show efficacy of 77.8% against Covid
​ By
IANS
|
​ 93 Views
Final Phase-3 results of Covaxin show efficacy of 77.8% against Covid. Image Source: IANS News
New Delhi, July 3 : Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic COVID-19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus 106 in the placebo group.
Bharat Biotech has concluded final analysis for Covaxin efficacy from Phase 3 clinical trials.
Efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19. Safety analysis demonstrates adverse events reported were similar to placebo, with 12 per cent of subjects experiencing commonly known side effects and less than 0.5 per cent of subjects feeling serious adverse events. ....

United States , New Delhi , Priya Abraham , Krishna Ella , Indian Covaxin , Balram Bhargava , Suchitra Ella , National Institute Of Virology , National Institutes Of Health , Indian Council Of Medical Research , Department Of Health Research , National Institutes , Data Safety Monitoring Board , Bharat Biotech , Managing Director , Secretary Department , Health Research , Director General Indian Council , Medical Research , Joint Managing Director , Director National Institute , Use Listing , ஒன்றுபட்டது மாநிலங்களில் , புதியது டெல்ஹி , கிருஷ்ணா எல்லா , பால்ராம் பார்கவா ,